NHS 'soup and shake' diet puts almost 1/3 of type 2 diabetes cases in remission
A study found that the NHS's "soup and shake" diet helped nearly one-third of type 2 diabetes participants achieve remission, with plans to expand the program to 50,000 participants.
Read original article
A recent study has shown that the NHS's "soup and shake" diet, which involves an 800-calorie meal replacement plan, has led to nearly one-third of participants with type 2 diabetes achieving remission. The program, available to individuals aged 18 to 65 diagnosed with type 2 diabetes, provides low-calorie products for three months, resulting in significant weight loss before transitioning to a normal diet with support. The study, published in the Lancet Diabetes and Endocrinology journal, analyzed data from 1,740 participants, revealing that 32% of those who completed the program had their diabetes in remission, with an average weight loss of 15.9 kg (35 lbs). NHS leaders are considering expanding the program, which currently serves 10,000 people annually, due to its promising results. The initiative, launched in 2020, has already seen over 25,000 participants, and plans are in place to increase capacity to 50,000 over five years with a £13 million investment. Experts emphasize the importance of support for individuals on their weight loss and remission journey, particularly for those recently diagnosed and younger patients, as obesity remains a significant health challenge in the UK.
- The NHS "soup and shake" diet has led to remission in nearly one-third of type 2 diabetes participants.
- The program involves an 800-calorie meal replacement diet followed by support for reintroducing normal foods.
- A study showed an average weight loss of 15.9 kg (35 lbs) among participants.
- Plans are underway to expand the program to 50,000 participants over five years.
- Support is crucial for individuals on their weight loss and remission journey, especially for younger patients.
Related
A 5,2 Intermittent Fasting Meal Replacement Diet for Adults with Diabetes
A randomized trial compared 5:2 intermittent fasting with metformin and empagliflozin in diabetic adults. Results showed improved glycemic control with reduced HbA1c levels and fasting glucose, suggesting potential benefits for diabetes management.
'Skinny jabs': weight-loss drugs set for new boom as generic versions emerge
Medicines like Wegovy and Saxenda, known as "skinny jabs," are gaining popularity for weight loss. Generic versions, like Teva's generic Victoza, are expected to increase accessibility and affordability, benefiting a broader population. Novo Nordisk invests $4 billion to meet rising demand.
Children's daily sugar consumption halved just a year after tax, study finds
A study found UK children's sugar consumption halved post sugar tax. Despite exceeding guidelines, experts propose expanding tax to improve health. Success in soft drinks suggests extending to other products for healthier diets.
Weight-loss drugs are causing people to spend less at the grocery store: study
A study by Grocery Doppio shows weight-loss medications like Ozempic and Wegovy lead users to spend less on groceries, buy healthier foods, and significantly reduce purchases of snacks and sugary items.
The Calorie-Restriction Experiment (2009)
The Calorie-Restriction Experiment (Calerie) studies the effects of a 25% caloric intake reduction on aging and diseases in 132 participants, showing potential benefits for cardiovascular health and cancer risk.
9 comments> Patients are given low-calorie meal replacement products such as soups, milkshakes and snack bars for three months
Something that goes below the radar is adherence - when someone else provides you with every single meal, sticking to a diet is much easier compared to when you're on your own and every meal is a choice that you make. It would be interesting to know how many people go back to their old habits once the program ends.
One good article I found about this is
https://www.mynutritionscience.com/p/total-diet-replacement
Total diet replacement has effects on the level of new obesity drugs. Adherence is actually very good
I would love the ease of not having to cook, buy food, to eat healthily
Related
A 5,2 Intermittent Fasting Meal Replacement Diet for Adults with Diabetes
A randomized trial compared 5:2 intermittent fasting with metformin and empagliflozin in diabetic adults. Results showed improved glycemic control with reduced HbA1c levels and fasting glucose, suggesting potential benefits for diabetes management.
'Skinny jabs': weight-loss drugs set for new boom as generic versions emerge
Medicines like Wegovy and Saxenda, known as "skinny jabs," are gaining popularity for weight loss. Generic versions, like Teva's generic Victoza, are expected to increase accessibility and affordability, benefiting a broader population. Novo Nordisk invests $4 billion to meet rising demand.
Children's daily sugar consumption halved just a year after tax, study finds
A study found UK children's sugar consumption halved post sugar tax. Despite exceeding guidelines, experts propose expanding tax to improve health. Success in soft drinks suggests extending to other products for healthier diets.
Weight-loss drugs are causing people to spend less at the grocery store: study
A study by Grocery Doppio shows weight-loss medications like Ozempic and Wegovy lead users to spend less on groceries, buy healthier foods, and significantly reduce purchases of snacks and sugary items.
The Calorie-Restriction Experiment (2009)
The Calorie-Restriction Experiment (Calerie) studies the effects of a 25% caloric intake reduction on aging and diseases in 132 participants, showing potential benefits for cardiovascular health and cancer risk.